Readying to Deploy Dx Products, Rosetta Genomics' CEO Moves to US | GenomeWeb
NEW YORK (GenomeWeb News) - Rosetta Genomics said today that its CEO, Amir Avniel, has moved his office from the company's headquarters in Rehovot, Israel, to New York as part of a plan to expand its US operations.
The company said the move will "facilitate the expected launch of Rosetta Genomics' first products, growth through partnerships and collaborations, as well as corporate operations in the US."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.